Featured
The Neuro-Chemical Blur: How Shiseido’s Cortisol-Reducing Skincare is Triggering an FDA Classification Crisis
Shiseido’s launch of "Synapse Glow," a cortisol-reducing neuro-peptide skincare line, is triggering an FDA classification crisis by blurring the lin...
Read Full Story →